Brexpiprazole (Rexulti): a new monotherapy for schizophrenia and adjunctive therapy for major depressive disorder.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927015 | PMC |
Publication Analysis
Top Keywords
brexpiprazole rexulti
8
rexulti monotherapy
8
monotherapy schizophrenia
8
schizophrenia adjunctive
8
adjunctive therapy
8
therapy major
8
major depressive
8
depressive disorder
8
disorder brexpiprazole
4
brexpiprazole
2
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!